类降脂药
化学
过氧化物酶体增殖物激活受体
脚手架
药理学
受体
生物化学
他汀类
生物
医学
生物医学工程
作者
Letizia Giampietro,Alessandra Ammazzalorso,Rosa Amoroso,Barbara De Filippis
出处
期刊:ChemMedChem
[Wiley]
日期:2019-04-08
卷期号:14 (11): 1051-1066
被引量:27
标识
DOI:10.1002/cmdc.201900128
摘要
Abstract Fibrates are a class of phenoxyisobutyric acid derivatives mainly used as anti‐hyperlipidemic agents. The fibrate scaffold has undergone a variety of chemical modifications, providing a wide spectrum of biological activities. Within the last few years, the majority of new synthetic fibrate derivatives have demonstrated hypolipidemic activity through peroxisome proliferator‐activated receptor α (PPARα) activation. However, some compounds containing the fibrate scaffold have shown different pharmacological properties, also independent of PPARα activation, such as anti‐inflammatory, analgesic, antioxidant, and antiplatelet activities. The aim of this review is to highlight the structure–activity relationships (SAR) in evaluating the significance of fibrates in the field of medicinal chemistry.
科研通智能强力驱动
Strongly Powered by AbleSci AI